{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:52:12Z","timestamp":1785415932569,"version":"3.56.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"DOI":"10.1186\/s12981-025-00708-w","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T08:47:58Z","timestamp":1738226878000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Brief communication: virological outcomes and dolutegravir resistance mutations in HIV-infected patients: a multicenter retrospective cohort study in Mozambique"],"prefix":"10.1186","volume":"22","author":[{"given":"Anna Maria","family":"Doro Altan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noorjehan","family":"Majid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elton","family":"Uamusse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia","family":"Rafael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zita","family":"Sidumo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Guidotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Ciccacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"key":"708_CR1","unstructured":"UNAIDS. Global HIV & AIDS statistics\u2014fact sheet. Global HIV & AIDS statistics\u2014Fact sheet. 2024. https:\/\/www.unaids.org\/en\/resources\/fact-sheet."},{"key":"708_CR2","unstructured":"UNAIDS. The urgency of now: AIDS at a crossroads. 2024. https:\/\/crossroads.unaids.org."},{"key":"708_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12977-022-00608-1","volume":"19","author":"AV Zhao","year":"2022","unstructured":"Zhao AV, Crutchley RD, Guduru RC, et al. A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection. Retrovirology. 2022;19:22.","journal-title":"Retrovirology"},{"key":"708_CR4","unstructured":"World Health Organization. Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidelines. Supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. 2018. https:\/\/iris.who.int\/bitstream\/handle\/10665\/277395\/WHO-CDS-HIV-18.51-eng.pdf?sequence=1."},{"key":"708_CR5","unstructured":"World Health Organization. HIV drug resistance: brief report 2024. 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240086319."},{"key":"708_CR6","unstructured":"UNAIDS. Country factsheets\u2014MOZAMBIQUE 2023. 2024. https:\/\/www.unaids.org\/en\/regionscountries\/countries\/mozambique. Accessed 26 Sep 2024."},{"key":"708_CR7","unstructured":"Minist\u00e9rio da Sa\u00fade, Direc\u00e7\u00e3o Nacional de Sa\u00fade P\u00fablica, PNC ITS-HIV\/SIDA. Normas Cl\u00ednicas Actualizadas para o seguimento do paciente HIV positive. 2019. https:\/\/comitetarvmisau.co.mz\/docs\/orientacoes_nacionais\/Circular_Normas_Cl\u00ednicas_Actualizadas_29_11_19.pdf."},{"key":"708_CR8","doi-asserted-by":"publisher","first-page":"1253661","DOI":"10.3389\/fviro.2023.1253661","volume":"3","author":"D Kamori","year":"2023","unstructured":"Kamori D, Barabona G. Dolutegravir resistance in sub-Saharan Africa: should resource-limited settings be concerned for future treatment? Front Virol. 2023;3:1253661.","journal-title":"Front Virol"},{"key":"708_CR9","doi-asserted-by":"publisher","first-page":"e733","DOI":"10.1016\/S2352-3018(23)00228-X","volume":"10","author":"T Loosli","year":"2023","unstructured":"Loosli T, Hossmann S, Ingle SM, et al. HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis. Lancet HIV. 2023;10:e733\u201341.","journal-title":"Lancet HIV"},{"key":"708_CR10","unstructured":"Community of Sant\u2019Egidio. DREAM Program in Mozambique. 2020. https:\/\/www.dream-health.org\/where-we-are\/mozambique\/?lang=en."},{"key":"708_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1386-6532(01)00252-9","volume":"25","author":"C Peduzzi","year":"2002","unstructured":"Peduzzi C, Pierotti P, Venturi G, et al. Performance of an in-house genotypic antiretroviral resistance assay in patients pretreated with multiple human immunodeficiency virus type 1 protease and reverse transcriptase inhibitors. J Clin Virol. 2002;25:57\u201362.","journal-title":"J Clin Virol"},{"key":"708_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100573","author":"S Kanters","year":"2020","unstructured":"Kanters S, Vitoria M, Zoratti M, et al. Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: a systematic literature review and network meta-analysis. EClinicalMedicine. 2020. https:\/\/doi.org\/10.1016\/j.eclinm.2020.100573.","journal-title":"EClinicalMedicine"},{"key":"708_CR13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/hiv.13050","volume":"22","author":"Y Punekar","year":"2021","unstructured":"Punekar Y, Parks D, Joshi M, et al. Effectiveness and safety of dolutegravir two-drug regimens in virologically suppressed people living with HIV: a systematic literature review and meta-analysis of real-world evidence. HIV Med. 2021;22:423\u201333.","journal-title":"HIV Med"},{"key":"708_CR14","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s41591-023-02763-0","volume":"30","author":"J Fokam","year":"2024","unstructured":"Fokam J, Inzaule S, Colizzi V, et al. HIV drug resistance to integrase inhibitors in low-and middle-income countries. Nat Med. 2024;30:618\u20139.","journal-title":"Nat Med"},{"key":"708_CR15","doi-asserted-by":"publisher","DOI":"10.1515\/ijamh-2022-0107","author":"F Ciccacci","year":"2023","unstructured":"Ciccacci F, Ismael F, Chume V, et al. Enhancing retention in care in HIV-infected adolescents during COVID-19 in Mozambique: results from the DREAM program. Int J Adolescent Med Health. 2023. https:\/\/doi.org\/10.1515\/ijamh-2022-0107.","journal-title":"Int J Adolescent Med Health"},{"key":"708_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002874","volume":"16","author":"MP Fox","year":"2019","unstructured":"Fox MP, Pascoe S, Huber AN, et al. Adherence clubs and decentralized medication delivery to support patient retention and sustained viral suppression in care: results from a cluster-randomized evaluation of differentiated ART delivery models in South Africa. PLoS Med. 2019;16: e1002874.","journal-title":"PLoS Med"},{"key":"708_CR17","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1097\/QAD.0000000000002284","volume":"33","author":"V Kouamou","year":"2019","unstructured":"Kouamou V, Manasa J, Katzenstein D, et al. Drug resistance and optimizing dolutegravir regimens for adolescents and young adults failing antiretroviral therapy. AIDS. 2019;33:1729\u201337.","journal-title":"AIDS"},{"key":"708_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25640","volume":"23","author":"L Long","year":"2020","unstructured":"Long L, Kuchukhidze S, Pascoe S, et al. Retention in care and viral suppression in differentiated service delivery models for HIV treatment delivery in sub-Saharan Africa: a rapid systematic review. J Int AIDS Soc. 2020;23: e25640.","journal-title":"J Int AIDS Soc"},{"key":"708_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.864489","author":"I Triulzi","year":"2022","unstructured":"Triulzi I, Ciccacci F, Palla I, et al. Improving male partner involvement in HIV-positive women\u2019s care through behavioral change interventions in Malawi (WeMen Study): a prospective, controlled before-and-after study. Front Public Health. 2022. https:\/\/doi.org\/10.3389\/fpubh.2022.864489.","journal-title":"Front Public Health"},{"key":"708_CR20","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0140-6736(23)01381-8","volume":"403","author":"A Mody","year":"2024","unstructured":"Mody A, Sohn AH, Iwuji C, et al. HIV epidemiology, prevention, treatment, and implementation strategies for public health. Lancet. 2024;403:471\u201392.","journal-title":"Lancet"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-025-00708-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-025-00708-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-025-00708-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T08:48:01Z","timestamp":1738226881000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00708-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["708"],"URL":"https:\/\/doi.org\/10.1186\/s12981-025-00708-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5676736\/v1","asserted-by":"object"}]},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We would like to express our sincere gratitude to Professor Federico Perno and Professor Maria Cristina Marazzi for their continuous support and inspiration for this work. Their guidance has been invaluable throughout this research. We also extend our heartfelt thanks to the African patients involved in this study. It is our hope that this research will contribute to improving their health and quality of life, and benefit many others in similar circumstances in the future.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Acknowledgements"}},{"value":"AMD conducted the analysis and drafted the manuscript.NM supervised data collection. SO reviewed the manuscript and provided insights into data interpretation. EU and MR managed the clinical data collection from patients. ZS supervised the laboratory data management. GG supervised data collection and reviewed the manuscript. FC conceptualized the study, supervised the analysis, and guided the interpretation of results.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The data that support the findings of this study are not openly available due to reasons of sensitivity, but are available from the corresponding author upon explicit and reasonable request.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}